Clinical Trials Logo

Atrial Flutter Typical clinical trials

View clinical trials related to Atrial Flutter Typical.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06406686 Not yet recruiting - Atrial Flutter Clinical Trials

Ablation Index in Standard vs. High Power Radiofrequency Ablation for Typical Atrial Flutter: A Randomized Study (AITAF)

AITAF
Start date: June 3, 2024
Phase: N/A
Study type: Interventional

A randomized controlled trial will be conducted to evaluate the efficacy of Ablation Index-guided high power - short duration (HPSD) ablation compared to conventional power settings in Cavotricuspid Isthmus (CTI) dependent atrial flutter. Participants will be randomized to receive either AI-guided HPSD ablation at 50 Watts or conventional power settings at 30 Watts. Both arms will use the Carto 3D mapping system and the QDOT MICRO ablation catheter (Biosense Webster). An anatomically contiguous line will be created with <6mm inter-lesion distance. After a standardized wait time of 30 minutes, ablation success will be assessed. The primary outcome is total radiofrequency ablation time. Secondary outcomes include procedural time, fluoroscopy time, safety outcomes, and 3-month freedom from recurrence. It is our expectation that HPSD will result in a shorter primary outcome.

NCT ID: NCT05904548 Not yet recruiting - Clinical trials for Atrial Flutter Typical

Atrial Flutter Ablation in the iCMR

VISABL-AFL
Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.